ArticlePDF Available

Solid-Type Primary Intraosseous Squamous-Cell Carcinoma in the Mandible: Report of a Rare Case

Authors:

Abstract and Figures

Primary intraosseous squamous cell carcinoma (PIOSCC) is a rare malignant neoplasm that has an exquisitely exclusive affection to the jawbone. It is defined as squamous cell carcinoma arising within the jaw and developing from residual odontogenic epithelium or from a preexisting odontogenic cyst or tumor. The solid-type of this tumor is a central jaw carcinoma arising de novo and has no initial connection with the oral mucosa. Herein, we report a case of solid-type PIOSCC involving the mandible in a 37-year-old male patient elucidating its histopathological and imaging findings. The patient underwent surgical resection followed by post-operative adjuvant radiotherapy. The close 2-year follow up of the patient revealed neither locoregional nor distant metastasis.
Content may be subject to copyright.
CASE REPORT
Solid-type primary intraosseous squamous-
cell carcinoma in the mandible: Report of a
rare case
Ohoud Alotaibi
a,*
, Nabil Al-Zaher
b
, Faiza Alotaibi
b
, Hatim Khoja
c
,
Ahmed Qannam
a
a
Department of Oral Medicine and Diagnostic Sciences, College of Dentistry, King Saud University, Riyadh, Saudi Arabia
b
Department of Otolaryngology, Head and Neck Surgery, King Faisal Specialist Hospital & Research Centre, Riyadh,
Saudi Arabia
c
Department of Pathology, King Faisal Specialist Hospital & Research Centre, Riyadh, Saudi Arabia
Received 22 May 2015; accepted 12 December 2015
Available online 16 January 2016
KEYWORDS
Primary intraosseous
squamous cell carcinoma;
Solid type;
Mandible;
Intraosseous neoplasms
Abstract
Primary intraosseous squamous cell carcinoma (PIOSCC) is a rare malignant neoplasm that has
an exquisitely exclusive affection to the jawbone. It is defined as squamous cell carcinoma aris-
ing within the jaw and developing from residual odontogenic epithelium or from a preexisting
odontogenic cyst or tumor. The solid-type of this tumor is a central jaw carcinoma arising
de novo and has no initial connection with the oral mucosa. Herein, we report a case of
solid-type PIOSCC involving the mandible in a 37-year-old male patient elucidating its
histopathological and imaging findings. The patient underwent surgical resection followed by
post-operative adjuvant radiotherapy. The close 2-year follow up of the patient revealed
neither locoregional nor distant metastasis.
Ó2016 King Faisal Specialist Hospital & Research Centre. Published by Elsevier Ltd. This is an
open access article underthe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-
nd/4.0/).
Introduction
Primary intraosseous squamous-cell carcinoma (PIOSCC) is a
rare jawbone malignant neoplasm uniquely exclusive to the
mandible and the maxilla. It was first designated by Loos [1]
in 1913 as central epidermoid carcinoma. Willis [2], in 1948,
http://dx.doi.org/10.1016/j.hemonc.2015.12.005
1658-3876/Ó2016 King Faisal Specialist Hospital & Research Centre. Published by Elsevier Ltd.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
*Corresponding author at: Department of Oral Medicine and
Diagnostic Sciences, College of Dentistry, King Saud University, P.O.
Box 60169, Riyadh 11545, Saudi Arabia.
E-mail address: drotaibi@ksu.edu.sa (O. Alotaibi).
Hematol Oncol Stem Cell Ther (2016) 9, 118122
Available at www.sciencedirect.com
ScienceDirec
t
journal homepage: www.elsevier.com/locate/hemonc
used the term intra-alveolar epidermoid carcinoma for this
lesion. Later, in 1971, Pindborg et al. [3] regarded it as a
primary intraosseous carcinoma. It was classified as an
odontogenic carcinoma and defined as ‘‘a squamous cell
carcinoma that arises within the jaw, with no initial connec-
tion with the oral mucosa and presumably develop from
residues of the odontogenic epithelium[3]. In the latest
World Health Organization classification, PIOSCC is subdi-
vided according to its potential origin into three types:
solid-type carcinoma, carcinoma arising from a keratocystic
odontogenic tumor, and carcinoma arising from an odonto-
genic cyst [4]. The diagnosis of PIOSCC is often challenging,
as other lesions need to be excluded, such as neoplasms
that metastasize to the jaws, gingival carcinomas that have
invaded the bone from the oral mucosa, and neoplasms that
originate from the maxillary sinus.
The solid-type PIOSCC is a central jaw carcinoma arising
de novo and has no initial connection with the oral mucosa.
It has been hypothesized that this lesion originates from
odontogenic epithelial rests, including rests of Malassez,
rests of Serres, and the reduced enamel epithelium
surrounding a tooth prior to eruption [5]. The solid-type
PIOSCC has been occasionally reported in the literature
[6], as it is the rarest type among PIOSCCs [7]. This report
describes a solid-type PIOSCC as a rare lesion arising from
the posterior area of the mandible, and reviews the
literature.
Case report
A 37-year-old male patient presented to the dental clinic at
the College of Dentistry, King Saud University, Riyadh, Saudi
Arabia, with a 3-month history of a left-cheek swelling that
has recently been associated with pain and impairment of
the sensation of his lower lip. Prior to his visit to our clinic,
the patient had been seen by a dentist elsewhere who
thought that the jaw swelling was due to infection, and
was managed with a tooth extraction without improvement.
The patient’s past medical history was otherwise unremark-
able. His intraoral examination showed a firm, nonfluctuant
swelling in the left retromolar area extending to the ramus
of the left mandible. No mucosal lesion or abnormalities
were present. The Orthopantomograph panoramic radio-
graph revealed an ill-defined irregular radiolucency at the
left mandibular ramus (Figure 1). The differential diagnoses
of the lesion included osteomyelitis, osteosarcoma,
intraosseous carcinoma, and ameloblastic carcinoma of
the mandible. Incisional biopsy from the ramus was per-
formed, which demonstrated features of squamous-cell car-
cinoma. Based on the clinical, radiographic, and histological
correlations, the diagnosis of intraosseous squamous-cell
carcinoma was established.
The patient was referred to a tertiary-care center that
specializes in head and neck cancer treatment, King Faisal
Specialist Hospital & Research Centre in Riyadh, for further
management. His head and neck computed-tomography
scan confirmed the presence of an irregular, destructive
soft-tissue mass lesion centered at the ramus of the left
mandible, which extended from the distal aspect of the
second molar to the posterior border of the ramus and from
the sigmoid notch to the angle of the mandible (Figure 2).
The computed-tomography scan of the chest, abdomen,
and pelvis showed no distant metastasis. There was a posi-
tive uptake in the mass lesion and bilateral upper jugulodi-
gastric lymphadenopathy on positron-emission-tomography
scan. The patient underwent tracheostomy, total radical
parotidectomy, left hemimandibulectomy, zygomatic-arch
excision, and manipulating fixation and wide local excision
of tumor in the left infratemporal and pterygoid fossae.
The histopathological assessment of the surgical specimen
confirmed that the tumor was an intraosseous squamous-
cell carcinoma, well to moderately differentiated (Figure 3).
The islands of the tumor cells extended into the bone
(Figure 4), and perineural invasion was noted. The tumor
size was 5.5 cm in the maximum dimension. The dissected
surgical specimen of the neck showed reactive lymph nodes
with no evidence of malignancy. Postoperative adjuvant
radiotherapy was administered, and the close follow-up of
the patient for nearly 2 years by the multidisciplinary team
revealed neither locoregional nor distant metastasis. The
patient is presently scheduled for facial reanimation.
Discussion
Solid-type PIOSCC is a rare malignant disease that arises from
remnants of the odontogenic apparatus in the jaw [5]. The
diagnosis of such lesion is challenging, as precise clinical
and pathological details are important in eliminating an oral
Figure 1 Panoramic radiograph showing a radiolucent area with ill-defined margins in the left mandibular ramus.
Squamous cell carcinoma in mandible 119
mucosal origin. Additionally, the histological sections should
be thoroughly examined to exclude the presence of any pre-
existing odontogenic lesions. Furthermore, a careful review
of the history and radiographic investigations is mandatory
Figure 2 Computed-tomography images: (A) axial computed-tomography slice; (B) coronal computed-tomography slice. An
ill-defined osteolytic lesion is observed at the center of the left mandibular ramus.
Figure 3 Photomicrograph of the lesion shows well to moderately differentiated squamous cells with cellular atypia and
pleomorphism. Keratin-pearl formation is seen (hematoxylin-and-eosin stain).
Figure 4 Microscopic examination showing infiltrative squamous-cell nests invading the bone (hematoxylin-and-eosin stain).
120 O. Alotaibi et al.
in excluding metastatic lesion from a distant site. Suei et al.
[8] proposed widely used criteria for diagnosing this type
of PIOSCC: (a) an intact overlying oral mucosa preceding
diagnosis, except due to tooth extraction or trauma; (b)
squamous-cell carcinoma with no histological evidence of
cystic components or other odontogenic tumor cells; and
(c) no metastatic deposit from a distant primary at the time
of diagnosis and throughout a follow-up period of more than
6 months. The present case fulfilled these criteria, and
hence, was classified as solid-type PIOSCC.
It is difficult to determine the real incidence of the solid-
type PIOSCC, owing to the paucity of well-documented
cases; however, it is the rarest type among PIOSCCs [7].
Lugakingira et al. [6] reviewed the literature between
1996 and 2010, and found 32 cases were of the solid-type
PIOSCC, 29 of mandibular, and four of maxillary types.
The most commonly affected site is the posterior mandible.
It has been reported that males were more commonly
affected than females [6]. Our patient had the expected
findings of male gender and involvement of the posterior
mandible. The age of affected patients ranged from
24 years to 76 years, where most of the cases occurred in
patients older than 50 years [6]. The patient who is the sub-
ject of this report was 37 years old at the time of diagnosis,
which is not a common finding. Few reports have described
solid-type PIOSCC in patients younger than 40 years [9–11].
The lesion at early stages is usually asymptomatic 10;
however, the most common presenting features of
advanced cases may include pain, swelling, numbness, and
trismus [6,8,11,12]. Our patient experienced a persistent
pain and paresthesia of the lower lip. He reported that he
had a tooth extraction at a private clinic that suspected
his initial symptoms to be due to a dental infection rather
than a tumor. It is worth mentioning that, because odonto-
genic infections occur more frequently, few clinicians
consider other entities; therefore, misdiagnosis and wrong
treatment may occur. It has been reported that inteross-
eous malignancy of the maxillofacial region can mimic
dental infection, and hence, gets misdiagnosed [13,14].
Yamada et al. [15] described cases of PIOSCC where they
were initially diagnosed as dental-infection-related
diseases.
The radiographic and histological investigations are
essential in diagnosing solid-type PIOSCC. Radiographically,
the lesion can show numerous destructive effects on the
bone. It usually exhibits an osteolytic appearance with
ill-defined and noncorticated borders [16,17], and our case
followed this pattern. The microscopic features of the solid-
type PIOSCC are not specific, as all neoplasms that originate
from squamous epithelium need to be considered [8].Itis
characterized by islands of epithelial malignant neoplasm
showing the features of squamous-cell carcinoma [4]. The
specimen should be thoroughly examined to confirm that
there is no evidence of odontogenic cysts or other odonto-
genic tumor components [8].
The mainstay of treatment for oral squamous-cell
carcinoma is usually surgery. External beam radiotherapy
with or without chemotherapy is generally employed in
three situations: (a) adjuvant to primary surgery to enhance
locoregional control for cases with unfavorable pathological
features, (b) primary treatment for cases unable to tolerate
or unsuited for surgery, and (c) salvage treatment in the
persistent or recurrent disease setting [18,19]. The treat-
ment of choice for PIOSCC, in particular, is radical surgical
resection [20]. The prognosis is generally poor, supporting
the need for an initial aggressive surgical intervention to
decrease the local recurrence rate [21]. The overall survival
rates at 1 year, 2 years, and 3 years have been reported as
75.7%, 62.1%, and 37.8%, respectively [11]. Although organ
preservation has become a prevalent treatment approach
for managing locoregionally advanced head and neck cancer
of the hypopharynx, the oropharynx, and the larynx, this
approach has not been widely applied to patients with
oral-cavity squamous-cell carcinoma. There are no
clinical-trial data comparing extensive primary surgical
approaches to organ preservation because of the paucity
of PIOSCC cases. All reports on PIOSCC strongly recommend
aggressive surgical intervention [6,22–24]. The need for
adjuvant chemotherapy and/or radiotherapy is controver-
sial [12,25]. However, several studies recommend postoper-
ative radiotherapy, which significantly improves the rates of
local and regional control and disease-free survival [20,26].
Zwetyenga et al. [21] concluded that surgery and postoper-
ative radiation therapy might have the best results.
In conclusion, we presented a case of solid-type PIOSCC
affecting the mandible, which may contribute to the
expanding database of this rare neoplasm. Although PIOSCC
is rare, it is important to be considered in the differential
diagnoses of any jaw radiolucency.
Conflicts of interest
The authors have no conflict of interest to declare.
References
[1] Loos D. Central epidermoid carcinoma of the jaws. Dtsch
Monatschr Zahnheilk 1913;31:308.
[2] Willis RA. Pathology of tumors. St. Louis: C.V. Mosby; 1948, p.
760–801.
[3] Pindborg JJ, Kramer IRH, Torloni H. Histological typing of
odontogenic tumours, jaw cysts, and allied
lesions. Geneva: World Health Organization; 1971.
[4] Barnes L, Eveson JW, Reichart P, Sidransky D. Pathology and
genetics of tumours of the head and neck. Lyon: World Health
Organization classification of tumours; 2005, p. 9.
[5] Eversole LR. Malignant epithelial odontogenic tumors. Semin
Diagn Pathol 1999;1(16):317–24.
[6] Lugakingira M, Pytynia K, Kolokythas A, Miloro M. Primary
intraosseous carcinoma of the mandible: case report and review
of the literature. J Oral Maxillofac Surg 2010;68:2623–9.
[7] Reichart PA, Philipsen HP. Odontogenic tumors and allied
lesions. London: Quintessence; 2004.
[8] Suei Y, Tanimoto K, Taguchi A, Wada T. Primary intraosseous
carcinoma: review of the literature and diagnostic criteria. J
Oral Maxillofac Surg 1994;52:580–3.
[9] Mu
¨ller S, Waldron CA. Primary intraosseous squamous carci-
noma. Report of two cases. Int J Oral Maxillofac Surg
1991;20:362–5.
[10] Nolan R, Wood NK. Central squamous cell carcinoma of the
mandible: report of case. J Oral Surg 1976;34:260–4.
[11] Thomas G, Pandey M, Mathew A, Abraham E, Francis A,
Somanathan T, et al. Primary intraosseous carcinoma of the
jaw: pooled analysis of world literature and report of two new
cases. Int J Oral Maxillofac Surg 2001;30:349–55.
Squamous cell carcinoma in mandible 121
[12] Nomura T, Monobe H, Tamaruya N, Kishishita S, Saito K,
Miyamoto R, et al. Primary intraosseous squamous cell carci-
noma of the jaw: two new cases and review of the literature.
Eur Arch Otorhinolaryngol 2013;270:375–9.
[13] Bhadage CJ, Vaishampayan S, Kolhe S, Umarji H. Osteosarcoma
of the mandible mimicking an odontogenic abscess: a case
report and review of the literature. Dent Update
2013;40:216–8.
[14] Selden HS, Manhoff DT, Hatges NA, Michel RC. Metastatic
carcinoma to the mandible that mimicked pulpal/periodontal
disease. J Endod 1998;24:267–70.
[15] Yamada T, Ueno T, Moritani N, Mishima K, Hirata A, Matsumura
T. Primary intraosseous squamous cell carcinomas: five new
clinicopathologic case studies. J Craniomaxillofac Surg
2009;37:448–53.
[16] Matsuzaki H, Katase N, Matsumura T, Hara M, Yanagi Y,
Nagatsuka H, et al. Solid-type primary intraosseous squamous
cell carcinoma of the mandible: a case report with histopatho-
logical and imaging features. Oral Surg Oral Med Oral Pathol
Oral Radiol 2012;114:e71–7.
[17] Kaffe I, Ardekian L, Peled M, Machtey E, Laufer D. Radiological
features of primary intra-osseous carcinoma of the jaws.
Analysis of the literature and report of a new case. Dentomax-
illofac Radiol 1998;27:209–14.
[18] Bessell A, Glenny A, Furness S, Clarkson JE, Oliver R, Conway
DI, et al. Interventions for the treatment of oral and oropha-
ryngeal cancers: surgical treatment. Cochrane Database Syst
Rev 2011;9:CD006205.
[19] Robertson AG, Soutar DS, Paul J, Webster M, Leonard AG,
Moore KP, et al. Early closure of a randomized trial: surgery
and postoperative radiotherapy versus radiotherapy in the
management of intra-oral tumours. Clin Oncol (R Coll Radiol)
1998;10:155–60.
[20] To EHW, Brown JS, Avery BS, Ward-Booth RP. Primary
intraosseous carcinoma of the jaws. Three new cases and a
review of the literature. Br J Oral Maxillofac Surg
1991;29:19–25.
[21] Zwetyenga N, Pinsolle J, Rivel J, Majoufre-Lefebvre C, Faucher
A, Pinsolle V. Primary intraosseous carcinoma of the jaws. Arch
Otolaryngol Neck Surg 2001;1(127):794–7.
[22] Chaisuparat R, Coletti D, Kolokythas A, Ord RA, Nikitakis NG.
Primary intraosseous odontogenic carcinoma arising in an
odontogenic cyst or de novo: a clinicopathologic study of six
new cases. Oral Surg Oral Med Oral Pathol Oral Radiol Endod
2006;101:194–200.
[23] Huang JW, Luo HY, Li Q, Li TJ. Primary intraosseous squamous
cell carcinoma of the jaws: clinicopathologic presentation and
prognostic factors. Arch Pathol Lab Med 2009;133:1834–40.
[24] Mohyuddin N, Yao M. Primary intraosseous carcinoma of the
anterior maxilla: an unusual case and review of the literature.
Ear Nose Throat J 2011;90:35–7.
[25] Bernier J, Domenge C, Ozsahin M, Matuszewska K, Lefe
`bvre JL,
Greiner RH, et al. Postoperative irradiation with or without
concomitant chemotherapy for locally advanced head and
neck cancer. N Engl J Med 2004;350:1945–52.
[26] Cooper JS, Pajak TF, Forastiere AA, Jacobs J, Campbell BH,
Saxman SB, et al. Postoperative concurrent radiotherapy and
chemotherapy for high-risk squamous-cell carcinoma of the
head and neck. N Engl J Med 2004;350:1937–44.
122 O. Alotaibi et al.
... The standard treatment of PIOSCC involves combining chemotherapy and postoperative http://otm.tjh.com.cn radiotherapy [5][6][7] . Complete resection is performed based on the prognosis before extensive involvement of adjacent tissues or lymph node metastases; early aggressive surgical treatment helps to reduce local recurrence [8] . ...
... The early symptoms are not obvious. When the tumor encroaches on the alveolar nerve, toothache, tooth loosening, a non-healing wound after tooth extraction, and lower lip numbness occur [7,9] . In this case, the patient experienced toothache, for which he underwent tooth extraction. ...
Article
Primary intraosseous squamous cell carcinoma (PIOSCC) is a rare malignant tumor that occurs predominantly in the jaw. Pathological evidence shows that PIOSCC originates from the residual odontogenic epithelium and a preexisting odontogenic cyst or tumor. Here, we report the case of a 63-year-old man with central squamous cell carcinoma of the mandible. On the basis of imaging and histopathology reports, the patient was diagnosed with PIOSCC of the jaw. Subsequently, he was treated with postoperative adjuvant chemotherapy. During a postoperative follow-up visit in the ninth month, mandibular computed tomography (CT) scanning and bone imaging revealed local recurrence and condylar invasion. Therefore, radiation along with chemotherapy was administered. This case study adds to the literature on PIOSCC and widens the understanding of its diagnosis, treatment, and prognosis.
... 2,3 Diagnosis of PIOC and NOS is often challenging, as other lesions need to be excluded, such as metastasizing neoplasms to the jaws, gingival carcinomas that have invaded the bone, and neoplasms originating from the maxillary sinus. 4 The 3-year survival rate of PIOC and NOS is 37%. 5 The treatment of choice is surgical excision, which usually declines for cosmetic reasons. 6 Ameloblastoma is a rare neoplasm originating from odontogenic sources; its incidence rate is 0.5 cases per million populations. ...
Article
Full-text available
Primary Intraosseous Carcinoma, Not Otherwise Specified (PIOC, NOS) is an extremely rare neoplasm defined as squamous cell carcinoma in the mandible, presumably from the residue of odontogenic epithelium. The diagnosis is often challenging, and the prognosis is poor. The treatment of choice is surgical excision but usually declined for cosmetic reasons. A 41-year-old Melanesian woman with a mass in her right jaw since two years ago but rapidly growing in the last six months, accompanied with pain. Irregular hard mass was found in the right mandible. Radiology studies revealed lytic tumors, likely infiltrating. No metastasis was found. The first biopsy revealed acanthomatous ameloblastoma, and the second biopsy revealed pseudoepitheliomatous hyperplasia. Wide excision was then conducted with pathology results of PIOC and NOS with some features of ameloblastic carcinoma. This case may arise from a previous benign precursor. Further genetic information may be needed. The treatment of choice is surgical excision. The prognosis needs further follow-up. Primary intraosseous carcinoma, not otherwise specified (PIOC, NOS) merupakan keganasan odontogenik yang langka. Diagnosisnya sulit dengan prognosis buruk. Tata laksana utama adalah bedah eksisi yang cenderung ditolak karena alasan estetik. Seorang perempuan ras Melanesia usia 41 tahun, mengeluh benjolan rahang kanan sejak dua tahun dan makin membesar terutama 6 bulan terakhir disertai nyeri. Massa tidak teratur dengan batas tidak jelas di mandibula kanan dengan ukuran 10 x 8 x 4 cm. Pemeriksaan radiologis menegaskan massa infiltratif, tetapi tidak menemukan anak sebar. Biopsi awal menunjukkan ameloblastoma, biopsi selanjutnya menunjukkan pseudoepitheliomatous hyperplasia. Eksisi luas dilakukan dan patologi menemukan PIOC, NOS dengan sebagian ciri ameloblastic carcinoma. Patologi dari tiga biopsi menunjukkan massa jinak odontogenik yang mengalami inflamasi kronis kemudian menjadi ganas. Prognosis masih belum bisa dipastikan.
... 2,3 Diagnosis of PIOC and NOS is often challenging, as other lesions need to be excluded, such as metastasizing neoplasms to the jaws, gingival carcinomas that have invaded the bone, and neoplasms originating from the maxillary sinus. 4 The 3-year survival rate of PIOC and NOS is 37%. 5 The treatment of choice is surgical excision, which usually declines for cosmetic reasons. 6 Ameloblastoma is a rare neoplasm originating from odontogenic sources; its incidence rate is 0.5 cases per million populations. ...
Article
Full-text available
p>Primary Intraosseous Carcinoma, Not Otherwise Specified(PIOC, NOS) is an extremely rare neoplasm defined as squamous cell carcinoma in the mandible, presumably from the residue of odontogenic epithelium. The diagnosis is often challenging, and the prognosis is poor. The treatment of choice is surgical excision but usually declined for cosmetic reasons. A 41-year-old Melanesian woman with a mass in her right jaw since two years ago but rapidly growing in the last six months, accompanied with pain. Irregular hard mass was found in the right mandible. Radiology studies revealed lytic tumors, likely infiltrating. No metastasis was found. The first biopsy revealed acanthomatous ameloblastoma, and the second biopsy revealed pseudoepitheliomatous hyperplasia. Wide excision was then conducted with pathology results of PIOC and NOS with some features of ameloblastic carcinoma. This case may arise from a previous benign precursor. Further genetic information may be needed. The treatment of choice is surgical excision. The prognosis needs further follow-up. Primary intraosseous carcinoma, not otherwise specied (PIOC, NOS) merupakan keganasan odontogenik yang langka. Diagnosisnya sulit dengan prognosis buruk. Tata laksana utama adalah bedah eksisi yang cenderung ditolak karena alasan estetik. Seorang perempuan ras Melanesia usia 41 tahun, mengeluh benjolan rahang kanan sejak dua tahun dan makin membesar terutama 6 bulan terakhir disertai nyeri. Massa tidak teratur dengan batas tidak jelas di mandibula kanan dengan ukuran 10 x 8 x 4 cm. Pemeriksaan radiologis menegaskan massa infiltratif, tetapi tidak menemukan anak sebar. Biopsi awal menunjukkan ameloblastoma, biopsi selanjutnya menunjukkan pseudoepitheliomatous hyperplasia. Eksisi luas dilakukan dan patologi menemukan PIOC, NOS dengan sebagian ciri ameloblastic carcinoma. Patologi dari tiga biopsi menunjukkan massa jinak odontogenik yang mengalami inflamasi kronis kemudian menjadi ganas. Prognosis masih belum bisa dipastikan.</p
... (35) La sobrevida de los pacientes con carcinoma intraóseo primario se eleva al 62 % a los 2 años y 38 % a los 5 años, y la recurrencia de este a los 1, 2 y 5 años son de 48,8 %, 55,7 % y 75,9 %, respectivamente. (30,32,36,37) El universo de quistes odontogénicos existentes en el total de los artículos revisados asciende a 44 823, de los cuales 9 806 se presentaron como quiste dentígero resultando ...
Article
Full-text available
Introduction: Malignancy of dentigerous cyst into primary intraosseous carcinoma is infrequent and scantily documented in the literature. It represents 1% to 2.5% of the total odontogenic tumors and is exclusive of maxillary bones. It is more common among men aged around 50 years. Its clinical characteristics are edema, tooth mobility and paresthesia, and in most cases an absence of pain. These features hamper its diagnosis and pose a challenge to pathologists. Objective: Review the prevalence of primary intraosseous carcinoma derived from dentigerous cysts as published in PubMed in the last 15 years. Methods: A literature review was conducted of papers published in the last 15 years. The database PubMed was consulted using the following search terms: “dentigerous cyst prevalence”, “primary intraosseous squamous cell carcinoma”, “dentigerous primary intraosseous squamous cell carcinoma”. The papers included were in English or Spanish. Of the 217 papers obtained, 39 were selected for data crossing. Data analysis and integration: Recognition of a condition as aggressive as primary intraosseous carcinoma derived from a dentigerous cyst requires examination of its clinical and radiographic characteristics as well as its symptoms. Its close relationship to dentigerous cyst, the most prevalent of developmental cysts, makes it necessary to gain an accurate and deep understanding of both. Primary intraosseous carcinoma poses a challenge to clinicians due to its low symptomatology and poor survival. Of the total 44 823 odontogenic cysts studied, 9 806 were diagnosed as dentigerous cysts and 22 maligned into primary intraosseous carcinoma, for 0.32% of the total. Conclusions: Malignation of a dentigerous cyst into primary intraosseous carcinoma has a low incidence and a silent presentation, which hampers its early diagnosis. Protocol biopsy is recommended for each case of dentigerous cyst to prevent the poor survival caused by primary intraosseous carcinoma.
... Se define como el carcinoma que surge dentro de los maxilares a partir del epitelio odontogénico residual o de un quiste o tumor odontogénico preexistentes. 1 Este carcinoma fue descrito por primera vez por Loos en 1913 como un carcinoma epidermoide central de la mandíbula. En 1948 se cambió el nombre a carcinoma epidermoide intraalveolar. ...
Article
Objective: The purpose of this study was to investigate the prognostic factors and treatment of primary intraosseous carcinoma. Methods: Patients diagnosed with primary intraosseous carcinoma and received treatment in Sichuan cancer hospital from 2000 to 2019 were followed up and retrospectively reviewed. Results: A total of 28 patients were included in the study, with a mean age of 60 years (60±10.11). The 2-year and 5-year overall survival were 60.7% and 38.5% respectively. In the univariate analysis, surgery combined with adjuvant therapy improved the overall survival compared with surgery or radiotherapy alone (P=0.035), and patients received postoperative adjuvant radiotherapy had a higher overall survival than those who received radical radiotherapy (P = 0.01). In addition, patients with well differentiated tumors have increased progression free survival (P=0.01). Multivariate analyses showed that radiotherapy was an independent indicator for overall survival (P = 0.007). Conclusions: surgery combined with adjuvant therapy is the superior treatment strategy for primary intraosseous carcinoma at present. This study is the first to confirm the positive role of radiotherapy in treating primary intraosseous carcinoma with data to back it up.
Preprint
Full-text available
Objective: The purpose of this study was to investigate the prognostic factors and treatment of primary intraosseous carcinoma (PIOC). Methods: Patients who diagnosed with PIOC and received treatment in Sichuan cancer hospital from 1996 to 2020 were followed up and retrospectively reviewed. Univariate and multivariate analyses base on clinical-pathological characteristics and therapeutic modalities were performed using the Log rank test and Cox regression model respectively. Result: A total of 28 patients were included in the study, with a mean age of 60 years (60±10.11). The 2-year and 5-year overall survival (OS) were 60.7% and 38.5% respectively. In the univariate analysis, surgery combined with adjuvant therapy improved the OS compared with surgery or radiotherapy alone (P=0.035), and patients received postoperative adjuvant radiotherapy had a higher OS than those who received radical radiotherapy (P = 0.01). In addition, patients with well differentiated tumors tent to have increased progression free survival (PFS) (P=0.01). Multivariate analyses showed that radiotherapy was independent indicators for OS (HR: 0.212, 95% CI: 0.068–0.660, P = 0.007). Conclusion: surgery combined with adjuvant therapy is the superior treatment strategy for primary intraosseous carcinoma at present. This study is the first to report the important role of radiotherapy in the treatment of primary intraosseous carcinoma. Mini Abstract:surgery plus adjuvant therapy is the preferred treatment for primary intraosseous carcinoma and it is first to illustrate the important role of radiotherapy.
Article
Full-text available
Introduction Primary intraosseous carcinoma, NOS (PIOC), is a rare malignancy which has been described in the maxilla and mandible often arising from odontogenic cysts. The authors describe a case of PIOC arising from a dentigerous cyst associated with a lower right third molar in 78‐year‐old male. Aims To demonstrate that seemingly innocuous pathology may represent a malignant process. In the presence of ‘red‐flag’ symptoms, one must consider alternative diagnoses and action them accordingly. Findings and Discussion The initial clinical and radiographic features suggested a common innocuous presentation, although other features which presented later were suggestive of malignancy. PIOC is treated conventionally by radical surgery to achieve a disease‐free margin with adjuvant neck dissection. In the case described, the patient underwent hemi‐mandibulectomy with neck dissection and fibula free flap reconstruction. Conclusion Pathology associated with third molars is extremely common, very occasionally malignancy can mimic these more common conditions. As such, careful clinical examination of the affected site and neighbouring structures (including the lymph nodes of the head and neck) should be routinely performed in all patients. Even in the presence of typical features clinical and radiographic features, tissue samples should be sent for histopathological analysis of what may appear to be harmless follicular or early cystic tissue.
Article
Primary intraosseous carcinoma (PIOC), NOS is a rare malignancy occurring in the jaw bones. It may arise de novo, or more commonly develop from pre‐existing lesions such as odontogenic cysts or tumours. In this manuscript, we describe a case of PIOC in the mandible of a 17‐year‐old male. Complicating factors were a history of familial hemophagocytic lymphohistiocytosis and Griscelli syndrome. Management included surgical removal and planned adjuvant chemoradiation. The relevant literature is reviewed with respect to PIOC in a paediatric population.
Article
Full-text available
Primary intraosseous carcinoma of the head and neck is rare, and lesions isolated to the anterior maxilla are obviously even more rare. The diagnosis of intraosseous carcinoma can be difficult, and it must be based on strict criteria. We report the case of a 40-year-old man who was referred for definitive treatment of a cancerous lesion of the anterior maxilla. The patient's mass had initially been thought to be a benign odontogenic cyst. The patient was treated with surgery and prosthetic rehabilitation. We describe the clinical presentation, pertinent workup including imaging, and the treatment of this case, and we review the literature.
Article
Inflammatory lesions, like periapical/odontogenic abscesses, are by far the most common pathologic condition of the jaws. Radiographically, these lesions commonly manifest as widening of periodontal ligament space, discontinuity of lamina dura and ill-defined periapical radiolucency. There are some rare disorders which could cause similar radiographic changes in the jaw bone. With careful scrutiny of periapical radiolucency, regular periodic follow-up radiographs and histo-pathologic examination, the periapical abscess or infection can be differentiated from rare fatal disorders. This paper highlights the need for vigilant examination of even the commonest, innocuous-appearing periapical changes which sometimes are produced by some rare fatal disorders.
Article
Background: Primary intraosseous squamous cell carcinoma is very rare. We report two cases of primary intraosseous squamous cell carcinoma of the jaw, one arising from an odontogenic cyst and the other arising de novo. Methods and results: The first case was a 76-year-old man with right mandible pain. A panoramic radiography and computed tomography revealed a large mandibular radiolucency. A biopsy revealed squamous cell carcinoma, and radiotherapy and hemimandibulectomy were performed. The second case was a 50-year-old man with lymph node swelling on the left neck. Squamous cell carcinoma of the lymph node was suspected after fine needle biopsy. After left neck dissection, histological testing of the odontogenic cyst revealed squamous cell carcinoma, of which the mandible was thought to be the primary site. Conclusion: Our two cases have no recurrence, and panoramic radiography was a useful tool in the detection of mandible disease.
Article
Primary intraosseous squamous cell carcinoma (PIOSCC) is a rare malignant odontogenic tumor arising from odontogenic epithelial remnants within the jawbones. PIOSCC is histopathologically divided into 3 types: solid-type carcinoma, carcinoma derived from a keratocystic odontogenic tumor, and carcinoma derived from an odontogenic cyst. In this article, we report a case of solid-type PIOSCC involving reactive bone formation in the mandible in a 60-year-old female patient together with its histopathological and imaging findings.
Article
Primary intraosseous squamous cell carcinomas (PIOSCCs) are rare malignant tumours which arise from odontogenic epithelial remnants. Herein we report five new PIOSCC cases, affecting three female and two male patients with a mean age of 64.4 years. One case involved the maxilla and four cases occurred in the mandible. Typical radiographic findings were ill-defined radiolucencies. Histopathologically, four cases were diagnosed as well-differentiated PIOSCCs arising de novo or from odontogenic cysts. The remaining case was a moderately differentiated de novo PIOSCC. In four cases, treatment consisted of surgical removal with perioperative radiotherapy or chemotherapy. To date, there have been no recurrences or distant metastases in three cases. The lesion was not locally controlled in one case and curative treatments were rejected in another case. PIOSCCs are thought to be important among radiolucent jaw lesions, and early diagnoses and surgical excision with sufficient margins of safety may allow for good prognoses.
Article
Background: Surgery is an important part of the management of oral cavity cancer with regard to both the removal of the primary tumour and removal of lymph nodes in the neck. Surgery is less frequently used in oropharyngeal cancer. Surgery alone may be treatment for early stage disease or surgery may be used in combination with radiotherapy, chemotherapy and immunotherapy/biotherapy. There is variation in the recommended timing and extent of surgery in the overall treatment regimens of people with these cancers. Objectives: To determine which surgical treatment modalities for oral cavity and oropharyngeal cancers result in increased overall survival, disease free survival, progression free survival and reduced recurrence. Search strategy: The following electronic databases were searched: the Cochrane Oral Health Group Trials Register (to 17 February 2011), the Cochrane Central Register of Controlled Trials (CENTRAL) (The Cochrane Library 2011, Issue 1), MEDLINE via OVID (1950 to 17 February 2011) and EMBASE via OVID (1980 to 17 February 2011). There were no restrictions regarding language or date of publication. Selection criteria: Randomised controlled trials where more than 50% of participants had primary tumours of the oral cavity or oropharynx, and which compared two or more surgical treatment modalities or surgery versus other treatment modalities. Data collection and analysis: Data extraction and assessment of risk of bias was undertaken independently by two or more review authors. Study authors were contacted for additional information as required. Adverse events data were collected from published trials. Main results: Seven trials (n = 669; 667 with cancers of the oral cavity) satisfied the inclusion criteria, but none were assessed as low risk of bias. Trials were grouped into three main comparisons. Four trials compared elective neck dissection (ND) with therapeutic neck dissection in patients with oral cavity cancer and clinically negative neck nodes, but differences in type of surgery and duration of follow-up made meta-analysis inappropriate. Three of these trials reported overall and disease free survival. One trial showed a benefit for elective supraomohyoid neck dissection compared to therapeutic ND in overall and disease free survival. Two trials found no difference between elective radical ND and therapeutic ND for the outcomes of overall survival and disease free survival. All four trials found reduced locoregional recurrence following elective ND.A further two trials compared elective radical ND with elective selective ND and found no difference in overall survival, disease free survival or recurrence. The final trial compared surgery plus radiotherapy to radiotherapy alone but data were unreliable because the trial stopped early and there were multiple protocol violations.None of the trials reported quality of life as an outcome. Two trials, evaluating different comparisons reported adverse effects of treatment. Authors' conclusions: Seven included trials evaluated neck dissection surgery in patients with oral cavity cancers. The review found weak evidence that elective neck dissection of clinically negative neck nodes at the time of removal of the primary tumour results in reduced locoregional recurrence, but there is insufficient evidence to conclude that elective neck dissection increases overall survival or disease free survival compared to therapeutic neck dissection. There is very weak evidence from one trial that elective supraomohyoid neck dissection may be associated with increased overall and disease free survival. There is no evidence that radical neck dissection increases overall survival compared to conservative neck dissection surgery. Reporting of adverse events in all trials was poor and it was not possible to compare the quality of life of patients undergoing different surgeries.